Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital

被引：0
|
作者：
Saez, Olga Martinez
Garcia, Arantzazu Martinez Barquin
Delgado, Maria Villamayor
Serrano, Cristina Saavedra
de la Fuente, Elena Corral
Domingo, Juan Jose Serrano
Huertas, Roberto Martin
Puertas, Pablo Reguera
Longo, Federico
Pachon, Vanessa
Garrote, Mercedes Rodriguez
Guillen, Carmen
Carrato, Alfredo
Monteagudo, Reyes Ferreiro
机构：
[1] Ramon & Cajal, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Madrird, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
815
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adjuvant Cisplatin and Docetaxel for Non-small Cell Lung Cancer The Hospital of the University of Pennsylvania Experience
    Weiss, Jared
    Eaby, Beth
    Stevenson, James
    Kucharczuk, John
    Cooper, Joel
    Kaiser, Larry
    Shrager, Joseph
    Rengan, Ramesh
    Langer, Corey
    Evans, Tracey
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 667 - 672
  • [42] RESULTS OF ADJUVANT RADIATION-THERAPY IN CANCER OF THE RECTUM - THOMAS-JEFFERSON-UNIVERSITY-HOSPITAL EXPERIENCE
    MOHIUDDIN, M
    DERDEL, J
    MARKS, G
    KRAMER, S
    CANCER, 1985, 55 (02) : 350 - 353
  • [43] Real impact of oxaliplatin in adjuvant chemotherapy for patients with stage III colon cancer based on the Multi-Institutional Registry of Large Bowel Cancer in Japan
    Yamada, Yasuhide
    Kobayashi, Hirotoshi
    Nagashima, Kengo
    Sugihara, Kenichi
    GLOBAL HEALTH & MEDICINE, 2022, 4 (05): : 259 - 267
  • [44] Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial
    Ruzzo, A.
    Galli, F.
    Galli, F.
    Rulli, E.
    Lonardi, S.
    Zagonel, V.
    Ronzoni, M.
    Ionta, M. T.
    Pella, N.
    Mucciarini, C.
    Labianca, R.
    Veltri, E.
    Sozzi, P.
    Barni, S.
    Nicolini, M.
    Biondi, E.
    Bramati, A.
    Turci, D.
    Buscaglia, M.
    Magnani, M.
    Graziano, F.
    ANNALS OF ONCOLOGY, 2017, 28 : 4 - 5
  • [45] Global clinical experience with adjuvant oxaliplatin/5-fluorouracil (5-FU)-based chemotherapy for colon cancer: ACCElox registry.
    Ji, J.
    Park, Y. S.
    Liu, M.
    Raafat, J.
    Szpak, W.
    Bouzid, K.
    Cornelio, G. H.
    Brenner, B.
    Ghosn, M.
    Zalcberg, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Effects of oxaliplatin-containing adjuvant chemotherapy on short-term survival of patients with colon cancer in Dr. Sardjito Hospital, Yogyakarta, Indonesia
    Wardhani, Yulia
    Hutajulu, Susanna Hilda
    Ferranti, Via Wahyu
    Fitriani, Zakia
    Taroeno-Hariadi, Kartika Widayati
    Kurnianda, Johan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (02) : 226 - 234
  • [47] Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis
    Cohen, R.
    Raeisi, M.
    Chibaudel, B.
    Yothers, G.
    Goldberg, R. M.
    Bachet, J. -B
    Wolmark, N.
    Yoshino, T.
    Schmoll, H. -J
    Haller, D. G.
    Kerr, R.
    Lonardi, S.
    George, T. J.
    Shacham-Shmueli, E.
    Shi, Q.
    Andre, T.
    de Gramont, A.
    ESMO OPEN, 2025, 10 (03)
  • [48] Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
    Zok, Jolanta
    Bienkowski, Michal
    Radecka, Barbara
    Korniluk, Jan
    Adamowicz, Krzysztof
    Duchnowska, Renata
    BMC CANCER, 2021, 21 (01)
  • [49] Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
    Gallois, Claire
    Shi, Qian
    Meyers, Jeffrey P.
    Iveson, Timothy
    Alberts, Steven R.
    de Gramont, Aimery
    Sobrero, Alberto F.
    Haller, Daniel G.
    Oki, Eiji
    Shields, Anthony Frank
    Goldberg, Richard M.
    Kerr, Rachel
    Lonardi, Sara
    Yothers, Greg
    Kelly, Caroline
    Boukovinas, Ioannis
    Labianca, Roberto
    Sinicrope, Frank A.
    Souglakos, Ioannis
    Yoshino, Takayuki
    Meyerhardt, Jeffrey A.
    Andre, Thierry
    Papamichael, Demetris
    Taieb, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (04) : 803 - +
  • [50] Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
    Jolanta Żok
    Michał Bieńkowski
    Barbara Radecka
    Jan Korniluk
    Krzysztof Adamowicz
    Renata Duchnowska
    BMC Cancer, 21
12345